ADAR1 Capital Management »

Biohaven shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Biohaven (BHVN) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Biohaven

Tip: Access up to 7 years of quarterly data

All positions including Biohaven held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biohaven by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $120k 2.2k 54.69

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Ea Series Trust Alpha Arch 1-3 (BOXX)
Roivant Sciences SHS (ROIV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Protagonist Therapeutics (PTGX)
Cytokinetics Com New (CYTK)
Keros Therapeutics (KROS)
Royalty Pharma Shs Class A (RPRX)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New
Ascendis Pharma A/s Sponsored Adr (ASND)
Arbutus Biopharma (ABUS)
Avrobio Ord (AVRO)
Beigene Sponsored Adr (BGNE)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)

View all positions for ADAR1 Capital Management

Top funds holding Biohaven

Vanguard Group
BlackRock
Stifel Financial
BlackRock
Henderson Group
Suvretta Capital Management
State Street Corporation
T. Rowe Price Associates
RP Management
Farallon Capital Management
Bellevue Group
Citadel Advisors
Geode Capital Management
Point72 Asset Management
Perceptive Advisors

View all funds holding Biohaven